Northwestern Medicine and Robert H. Lurie Comprehensive Cancer Center of Northwestern University | Strategic Alliance Partners

A young cancer survivor who underwent external beam radiation therapy and brachytherapy at 14 years old discusses her rare diagnosis, side effects and the nonlink to her Turner syndrome.

An expert gives an overview of the treatment options for uveal melanoma, and why he considers hope to be an essential part of the care plan.

Opdivo plus Cabometyx prolonged survival with minimal effects to their health status, which may highlight the need for patients to advocate for their quality of life when making treatment decisions.